RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONN Patent applications |
Patent application number | Title | Published |
20130158093 | GPR 17 Agonists and Screening Assay - The present invention is related to a method of determining a test compound's ability to modify the biological activity of a GPR17. Said method comprises, among others, the step of contacting the test compound with a GPR17, or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I. | 06-20-2013 |
20110312893 | METHOD FOR ISOLATING NEURAL CELLS WITH TENASCIN-R COMPOUNDS - The invention relates to a method for isolating neural cells using tenascin-R compounds, tenascin-R fragments particularly suited for said method and tenascin-R fusion proteins, to recombinant preparation of said tenascin-R compounds, and to a kit for carrying out said method and to the use of said method for preparing high-purity neural cell populations. The invention further relates to antibodies suitable for detecting and isolating tenascin-R compounds. | 12-22-2011 |
20110260814 | CONTINUOUSLY WOUND SOLENOID COIL WITH FINAL CORRECTION FOR GENERATING A HOMOGENEOUS MAGNETIC FIELD IN THE INTERIOR OF THE COIL AND ASSOCIATED OPTIMIZATION METHOD - Disclosed is a device for generating a uniform magnetic field and to an optimization method for magnetic fields in a sample space, the method providing specifications for producing such a device. The device comprises at least one field coil for generating the magnetic field and the turns of the field coil are continuously wound around the sample space and the turn diameter of the field coil changes continuously at least in a portion of the field coil along the longitudinal axis of the sample space. To this end, the correction of non-uniformities in the magnetic field caused by the finite length of the field coil is distributed over the entire field coil. In this way, the device can be implemented more easily and precisely than with the correction coils used according to the prior art for correcting non-uniformities. Instead of the existing series expansion of the magnetic field, the method for optimizing the magnetic field employs a power function in conjunction with simulation of the magnetic field based on the optimization parameters. This function can be used in a larger volume than the series expansion. | 10-27-2011 |
20110159012 | METHOD FOR ISOLATING NEURAL CELLS USING TENASCIN-R COMPOUNDS - The invention relates to a process for isolating neural cells using tenascin-R compounds, tenascin-R fragments and tenascin-R fusion proteins that are particularly suitable for such process, the recombinant preparation of such tenascin-R compounds, and a kit for performing this process, and the use of the process for preparing highly pure neural cell populations. The invention further relates to antibodies suitable for the detection and isolation of tenascin-R compounds. | 06-30-2011 |
20100210654 | NOVEL P2Y12 RECEPTOR ANTAGONISTS - The present invention relates to novel P2Y | 08-19-2010 |